Skip to main content

Table 6 Comparison of cellular factors levels between the co-infection and mono-infection groups

From: Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

Cellular Factors

Co-infected PCa (a) vs not co-infected PCa (b)

Co-infected Positive control (c) vs not co-infected control (d)

Co-infected PCa (a) vs HPV-mono-infected PCa (e)

Co-infected PCa (a) vs EBV-mono-infected PCa (f)

Co-infected PCa (a) and non-HPV/non-EBV PCa (g)

NF-κB

a: 26.9 ± 3.1

c: 21.6 ± 2.5

a: 26.9 ± 3.1

a: 26.9 ± 3.1

a: 26.9 ± 3.1

b: 17.8 ± 7.1

d: 8.2 ± 6

e: 20.3 ± 7.2

f: 18.4 ± 3.2

g: 12 ± 8

P* (0.0004)

P+ (0.004)

P$ (ns)

P^ (ns)

P# (0.0001)

TNF-α

a: 25.5 ± 2.7

c: 19.5 ± 3.1

a: 25.5 ± 2.7

a: 25.5 ± 2.7

a: 25.5 ± 2.7

b: 15.2 ± 6.8

d: 10.6 ± 6.3

e: 19 ± 7.6

f: 16.2 ± 4.8

g: 10.2 ± 6.3

P* (0.001)

P+ (ns)

P$ (ns)

P^ (0.04)

P# (0.0001)

IL-1

a: 18.4 ± 3.6

c: 18.3 ± 3.5

a: 18.4 ± 3.6

a: 18.4 ± 3.6

a: 18.4 ± 3.6

b: 14.2 ± 4.4

d: 6.7 ± 4.2

e: 16.1 ± 4.6

f: 12.5 ± 4.2

g: 7.1 ± 4

P* (ns)

P+ (0.004)

P$ (ns)

P^ (ns)

P# (0.0001)

IL-6

a: 21.3 ± 2.1

c: 19 ± 3.9

a: 21.3 ± 2.1

a: 21.3 ± 2.1

a: 21.3 ± 2.1

b:12.2 ± 5.2

d: 7.5 ± 5.6

e: 16.3 ± 6.5

f: 13.3 ± 5.2

g: 8.2 ± 1.6

P* (0.004)

P+ (0.003)

P$ (ns)

P^ (ns)

P# (0.001)

IL-8

a: 17.3 ± 4.9

c: 16.3 ± 3.2

a: 17.3 ± 4.9

a: 17.3 ± 4.9

a: 17.3 ± 4.9

b: 11.6 ± 6.1

d: 4.5 ± 3.8

e: 18.2 ± 6.1

f: 4.8 ± 3.9

g: 9.1 ± 3.6

P* (ns)

P+ (0.009)

P$ (ns)

P^ (0.01)

P# (ns)

IL-11

a: 21.8 ± 6.4

c: 17 ± 5

a: 21.8 ± 6.4

a: 21.8 ± 6.4

a: 21.8 ± 6.4

b: 14.3 ± 8.1

d: 6.1 ± 5.4

e: 20.6 ± 8.2

f: 14.3 ± 8.1

g: 10.7 ± 5.9

P* (ns)

P+ (ns)

P$ (ns)

P^ (ns)

P# (0.04)

IL-17

a: 15.2 ± 1.8

c: 13 ± 2

a: 15.2 ± 1.8

a: 15.2 ± 1.8

a: 15.2 ± 1.8

b: 8.7 ± 3.3

d: 3.4 ± 2.7

e: 13.2 ± 2.4

f: 8 ± 2.7

g: 7.3 ± 2.4

P* (0.008)

P+ (0.002)

P$ (ns)

P^ (0.006)

P# (0.003)

VEGF

a: 53.6 ± 3.8

c: 29.6 ± 1.5

a: 53.6 ± 3.8

a: 53.6 ± 3.8

a: 53.6 ± 3.8

b: 38.7 ± 7.3

d: 12.5 ± 4.8

e: 51.44 ± 3

f: 35.8 ± 4.7

g: 35.8 ± 3.6

P* (0.04)

P+ (ns)

P$ (ns)

P^ (0.02)

P# (0.02)

TGF-β

a: 21.5 ± 4.5

c: 16 ± 2

a: 21.5 ± 4.5

a: 21.5 ± 4.5

a: 21.5 ± 4.5

b: 13.9 ± 7.5

d: 6.6 ± 4.5

e: 18.2 ± 7.3

f: 13.3 ± 3.5

g: 11 ± 5.6

P* (ns)

P+ (ns)

P$ (ns)

P^ (0.03)

P# (0.01)

Rb

a: 2.3 ± 1

c: 1.6 ± 1.1

a: 2.3 ± 1

a: 2.3 ± 1

a: 2.3 ± 1

b: 10.5 ± 5.3

d: 15.3 ± 5.2

e: 2.7 ± 0.9

f: 12.4 ± 4.7

g: 12.3 ± 3.3

P* (< 0.0001)

P+ (< 0.0001)

P$ (ns)

P^ (< 0.0001)

P# (< 0.0001)

P53

a: 2.6 ± 0.9

c: 2.3 ± 0.5

a: 2.6 ± 0.9

a: 2.6 ± 0.9

a: 2.6 ± 0.9

b: 12.1 ± 6.2

d: 15.1 ± 5.7

e: 3.7 ± 1.4

f: 13.3 ± 5.4

g: 14.9 ± 5

P* (< 0.0001)

P+ (0.0006)

P$ (ns)

P^ (< 0.0001)

P# (< 0.0001)

ROS

a: 24.5 ± 5.8

c: 15.6 ± 3

a: 24.5 ± 5.8

a: 24.5 ± 5.8

a: 24.5 ± 5.8

b: 6.6 ± 8

d: 5.1 ± 4.4

e: 22.2 ± 5.3

f: 3.4 ± 1.9

g: 2.6 ± 2.1

P* (< 0.0001)

P+ (ns)

P$ (ns)

P^ (< 0.0001)

P# (< 0.0001)

RNS

a: 20 ± 9.4

c: 17.3 ± 3.2

a: 20 ± 9.4

a: 20 ± 9.4

a: 20 ± 9.4

b: 10.1 ± 9.7

d: 4 ± 3.7

e: 20.4 ± 10.6

f: 9.2 ± 9.3

g: 5.6 ± 4.3

P* (0.02)

P+ (0.01)

P$ (ns)

P^ (0.02)

P# (0.004)

Survivin

a: 22.5 ± 1

c: 21.3 ± 0.5

a: 22.5 ± 1

a: 22.5 ± 1

a: 22.5 ± 1

b: 13.7 ± 4.9

d: 7.4 ± 4

e: 19.5 ± 1.8

f: 17.2 ± 4.3

g: 12.3 ± 4.7

P* (< 0.0001)

P+ (< 0.0001)

P$ (ns)

P^ (ns)

P# (< 0.0001)

Bcl-2

a: 14.1 ± 1.2

c: 15.4 ± 1.3

a: 14.1 ± 1.2

a: 14.1 ± 1.2

a: 14.1 ± 1.2

b: 8.8 ± 3

d: 5 ± 2.6

e: 13.5 ± 1

f: 8 ± 2.1

g: 7.2 ± 1.9

P* (0.005)

P+ (0.0004)

P$ (ns)

P^ (0.005)

P# (0.001)

CD44

a: 10.6 ± 5.4

c: 9.3 ± 1.5

a: 10.6 ± 5.4

a: 10.6 ± 5.4

a: 10.6 ± 5.4

b: 7.2 ± 4.8

d: 3.5 ± 1.7

e: 3.7 ± 1.4

f: 10.8 ± 4.4

g: 3.9 ± 2

P* (ns)

P+ (ns)

P$ (0.03)

P^ (ns)

P# (0.01)

TWIST

a: 26.8 ± 6.7

c: 23 ± 2

a: 26.8 ± 6.7

a: 26.8 ± 6.7

a: 26.8 ± 6.7

b: 6.8 ± 10.1

d: 4.6 ± 4.9

e: 25.6 ± 9.9

f: 2.5 ± 1.3

g: 2.3 ± 1.4

P* (< 0.0001)

P+ (0.009)

P$ (ns)

P^ (< 0.0001)

P# (< 0.0001)

E-cad

a: 2.7 ± 0.6

c: 2.6 ± 0.5

a: 2.7 ± 0.6

a: 2.7 ± 0.6

a: 2.7 ± 0.6

b: 15.1 ± 7.7

d: 14.6 ± 4.6

e: 4.5 ± 3

f: 18 ± 5.8

g: 16.8 ± 6.9

P* (< 0.0001)

P+ (0.007)

P$ (ns)

P^ (< 0.0001)

P# (< 0.0001)

N-cad

a: 25.9 ± 6.8

c: 25.3 ± 7.3

a: 25.9 ± 6.8

a: 25.9 ± 6.8

a: 25.9 ± 6.8

b: 7.6 ± 9.8

d: 3.8 ± 5.5

e: 25.6 ± 9.7

f: 3.4 ± 1.8

g: 3.4 ± 2.5

P* (0.001)

P+ (0.02)

P$ (ns)

P^ (0.0004)

P# (0.0003)

PTPN13

a: 6.2 ± 7.6

c:2 ± 1

a: 6.2 ± 7.6

a: 6.2 ± 7.6

a: 6.2 ± 7.6

b: 10.5 ± 5.3

d: 14.1 ± 5.8

e: 3.6 ± 3.6

f: 12.7 ± 4.7

g: 12.5 ± 4

P* (ns)

P+ (0.002)

P$ (ns)

P^ (0.03)

P# (0.03)

SLUG

a: 3.5 ± 1.6

c: 3.2 ± 1.4

a: 3.5 ± 1.6

a: 3.5 ± 1.6

a: 3.5 ± 1.6

b: 1.8 ± 1.8

d: 0.96 ± 2.8

e: 4.3 ± 1.1

f: 0.9 ± 1.4

g: 1 ± 1.1

P* (ns)

P+ (ns)

P$ (ns)

P^ (0.004)

P# (0.01)

  1. Geometric Mean ± Standard Deviation, *: comparison between group a versus group b, +: comparison between group c versus group d, $: comparison between group e versus group f, ^: $: comparison between group g versus group h, FDR correction for multiple comparisons by Benjamini-Hochberg method